Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis

[1]  M. Urowitz,et al.  Nonlymphoma hematological malignancies in systemic lupus erythematosus , 2012, Arthritis Research & Therapy.

[2]  Gordon H Guyatt,et al.  Credibility of claims of subgroup effects in randomised controlled trials: systematic review , 2012, BMJ : British Medical Journal.

[3]  I. Roifman,et al.  Chronic inflammatory diseases and cardiovascular risk: a systematic review. , 2011, The Canadian journal of cardiology.

[4]  D. Ford.  Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia , 2010, Clinical lipidology.

[5]  F. Berrino,et al.  Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. , 2010, Blood.

[6]  J. Atkinson,et al.  Mutations in complement regulatory proteins predispose to preeclampsia , 2010 .

[7]  J. Salmon,et al.  Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. , 2010, Placenta.

[8]  David Moher,et al.  CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials , 2010, PLoS medicine.

[9]  David R Fernandez,et al.  mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus? , 2010, Discovery medicine.

[10]  A. Perl.  Systems biology of lupus: Mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment , 2010, Autoimmunity.

[11]  M. Fritzler,et al.  Latest update on the Ro/SS-A autoantibody system. , 2009, Autoimmunity reviews.

[12]  A. Perl,et al.  Pharmacotherapy of systemic lupus erythematosus , 2009, Expert opinion on pharmacotherapy.

[13]  P. Raggi,et al.  Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. , 2008, The Journal of rheumatology.

[14]  E. Barrett-Connor,et al.  Prevalence of Angina in Women Versus Men: A Systematic Review and Meta-Analysis of International Variations Across 31 Countries , 2008, Circulation.

[15]  D. Gladman,et al.  Lung cancer in systemic lupus erythematosus. , 2007, Lung cancer.

[16]  M. Lockshin,et al.  The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients , 2007, Nature Clinical Practice Rheumatology.

[17]  A. Perl,et al.  Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[18]  Joel Gagnier,et al.  The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. , 2005, Contemporary clinical trials.

[19]  J. Lambris,et al.  Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. , 2003, The Journal of clinical investigation.

[20]  G. Guyatt,et al.  In the dark: the reporting of blinding status in randomized controlled trials. , 2002, Journal of clinical epidemiology.

[21]  M. Abrahamowicz,et al.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. , 2001, Arthritis and rheumatism.

[22]  M. Ward.  Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[23]  N. Black.  CONSORT , 1996, The Lancet.

[24]  Cedars-Sinai Medical Center, Los Angeles. , 1984, The Mount Sinai journal of medicine, New York.

[25]  M. Knowling,et al.  Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  G. Diamond.  A clinically relevant classification of chest discomfort. , 1983, Journal of the American College of Cardiology.

[27]  G. A. Rose.  ISCHEMIC HEART DISEASE. CHEST PAIN QUESTIONNAIRE. , 1965, The Milbank Memorial Fund quarterly.